Skip to content
Recall Observatory FDA recall evidence

Drug product

Tikosyn (dofetilide) 125 mcg (0.125 mg), a) 14-count bottle (NDC 0069-5800-61), b) 60-count bottle (NDC 0069-5800-60), Rx Only, Manufactured by Pfizer Labs, Division of Pfizer, Inc., NY, NY 10017.

D-0292-2015

December 03, 2014

Class II

Product summary

Firm
Pfizer Inc.
Event
Event 69724
Status
Terminated
Classification
Class II
Quantity
31,569 HDPE Bottles
Official record key
drug-enforcement:D-0292-2015

Official wording

Reason: Failed Tablet/Capsule Specifications: Product being recalled due to the potential presence of cracked or broken capsules.

Code information: Lot # a) H79652, Exp. 10/15; b) H79653, Exp. 10/15

Distribution pattern: Pfizer shipped the affected product to 4,447 direct accounts. No federal government accounts received the affected product directly from Pfizer Inc.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Failed Tablet/Capsule Specifications: Product being recalled due to the potential presence of cracked or broken capsules.